Obesity

Weight Management Health Risks Type 2 Diabetes Treatment Options Hypertension Related Health Issues Market Trends Health Outcomes Medication Management BMI Monitoring

3 ARTICLES

2w ago

GLP-1 Treatments Fail to Boost Fitness and Risk Muscle Loss

A University of Virginia review warns that muscle loss from GLP-1 treatments could undermine long-term health gains without targeted exercise programs to preserve cardiorespiratory fitness.

5 ARTICLES

last mo.

Nice Proposes Annual Weight Monitoring for Millions with Long-Term Health Conditions

3 ARTICLES

5mo ago

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

25 ARTICLES

6mo ago

Study Maps Broad Health Impacts of Popular GLP-1 Weight-Loss Drugs

4 ARTICLES

7mo ago

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

9 ARTICLES

last yr.

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

4 ARTICLES

last yr.

Roche Accelerates Development of Promising Weight-Loss Pills

Obesity

GLP-1 Treatments Fail to Boost Fitness and Risk Muscle Loss

Liraglutide Cuts Chronic Migraine Days by More Than Half

NHS to Expand GP Prescriptions of Mounjaro for Weight Loss

UK to Trial Pharmacy-Based NHS Weight-Loss Jab Prescriptions

Nice Proposes Annual Weight Monitoring for Millions with Long-Term Health Conditions

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Study Maps Broad Health Impacts of Popular GLP-1 Weight-Loss Drugs

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

Roche Accelerates Development of Promising Weight-Loss Pills